Physician profile
Darnell E Blackmon
NPI 1831150655
$4,865.00
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,153 · 2020: $665 · 2021: $1,126 · 2022: $1,411 · 2023: $388 · 2024: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $510.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $1,400.42 | 2021-2023 | Puraply |
| Ortho Solutions INC | $429.77 | 2020-2022 | |
| Integra Lifesciences Corporation | $429.56 | 2019 | |
| Stryker Corporation | $372.72 | 2019 | |
| Arteriocyte Medical Systems, INC. | $336.37 | 2019-2020 | |
| Alevio, LLC | $265.00 | 2022 | |
| Smith+Nephew, INC. | $264.45 | 2019-2024 | Iodosorb Ointment 40g USA, Pico, Collagenase Santyl |
| Orthalign INC | $218.19 | 2021-2022 | |
| US Implant Solutions, LLC | $205.97 | 2021 | |
| Globus Medical, INC. | $158.71 | 2021 | |
| Pacira Therapeutics, INC. | $157.69 | 2019-2020 | |
| Anika Therapeutics, INC. | $125.41 | 2021 | |
| Grt US Holding, INC. | $115.70 | 2022 | |
| Bioventus LLC | $88.19 | 2019-2020 | |
| Horizon Therapeutics Plc | $71.46 | 2020-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Embody, INC. | $47.07 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $33.66 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $29.50 | 2022 | |
| Sanofi-Aventis U.S. LLC | $28.99 | 2019-2020 | |
| Next Science LLC | $27.79 | 2022 | |
| Zyla Life Sciences, INC. | $16.35 | 2020 | |
| Collegium Pharmaceutical, INC. | $15.70 | 2019 | |
| Ferring Pharmaceuticals INC. | $14.12 | 2019 | |
| Pfizer INC. | $12.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darnell Blackmon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.